Oral Biologics & Biosimilars Global Market Opportunities And Strategies To 2030

Oral Biologics & Biosimilars Global Market Opportunities And Strategies To 2030

Oral Biologics & Biosimilars Global Market Opportunities And Strategies To 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global oral biologics and biosimilars market.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
Description:

Where is the largest and fastest growing market for the oral biologics and biosimilars market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global oral biologics and biosimilars market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters
  • Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
  • Report Structure – This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography, segmentation by therapeutic mechanism, by disease, molecule type and by distribution channel.
  • Market Characteristics – The market characteristics section of the report defines and explains the oral biologics & biosimilars market. This chapter includes different services covered in the report and basic definitions.
  • Supply Chain – The supply chain section of the report defines and explains the key players in the oxygen market supply chain.
  • Product Analysis – The product analysis section of the report describes the leading products/services in the market along with key features and differentiators for those products/services.
  • Product Pipeline Analysis – This chapter gives the information on oral biologics & biosimilars product pipeline analysis.
  • Customer Information– This chapters covers recent customers’ trends/preferences in the global oxygen market.
  • Trends And Strategies – This chapter describes the major trends shaping the global oxygen market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Impact of COVID-19 – This section describes the impact of COVID-19 on the oral biologics and biosimilars market R&D funding market.
  • Global Oral Biologics & Biosimilars Comparative Analysis Of Overall Biologics & Oral Biologics – This section describes oral biologics & biosimilars comparative analysis of overall biologics and oral biologics.
  • Global Oral Biologics & Biosimilars Rise & Evolution – This section describes oral biologics & biosimilars market rise and evolution.
  • Oral Biologics & Biosimilars Companies’ Investment In Research And Development – This section describes oral biologics & biosimilars companies’ investment in research and development
  • Major Oral Biologics & Biosimilars Developments By Disease – This section describes major oral biologics & biosimilars developments by disease.
  • Global Market Size And Growth – This section contains the global historic (2015-2019) and forecast (2023F, 2025F, 2030F) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Market Segmentation – This section contains the market values (2015-2019, 2019-2023F, 2025F, 2030F) and analysis for segment by type in the market.
  • Regional Analysis – This section contains the historic (2015-2019), forecast (2019-2023F, 2025F, 2030F) market value and growth and market share comparison by region.
  • Regional Market Size And Growth – This section contains the region’s market size (2019), historic and forecast (2015-2019, and 2023F, 2025F, 2030F) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • Competitive Landscape – This section covers details on the competitive landscape of the global oral biologics & biosimilars market, estimated market shares and company profiles of the leading players.
  • Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies– This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for pharmaceuticals providers in terms of product offerings, geographic expansion, marketing strategies and target groups.
  • Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:

The global oral biologics and biosimilars market is segmented into -

By Disease: Diabetes; Arthritis & Chron's Disease; Cancer; Infectious Diseases; Other Autoimmune Disease; Others Diseases

By Molecule Type: Vaccines; Proteins & Peptides; Monoclonal Antibodies; Others

By Therapeutic Mechanism: TNF-Alpha; Lymphocyte Modulators; Interleukin Inhibitors; GPCR; Immunostimulants; Others

By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Merck & Co.; GlaxoSmithKline; Novo Nordisk; ALK-Abello A/S; Aimmune Therapeutics, Inc.

Countries: China, Japan, India, Australia, Indonesia, South Korea, USA, Brazil, UK, Germany, France, Russia.

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


1. Oral Biologics & Biosimilars Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
6.1.1. Segmentation By Geography
6.1.2. Segmentation By Disease
6.1.3. Segmentation By Molecule Type
6.1.4. Segmentation By Therapeutic Mechanism
6.1.5. Segmentation By Distribution Channel
7. Oral Biologics & Biosimilars Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Disease
7.2.1. Diabetes
7.2.2. Arthritis and Crohn’s Disease
7.2.3. Cancer
7.2.4. Infectious Disease
7.2.5. Other Autoimmune Disease
7.2.6. Other Diseases
7.3. Market Segmentation By Molecule Type
7.3.1. Vaccines
7.3.2. Monoclonal Antibodies
7.3.3. Proteins and Peptides
7.3.4. Others
7.4. Market Segmentation By Therapeutic Mechanism
7.4.1. Lymphocyte Modulators
7.4.2. Interleukin Inhibitors
7.4.3. Tumor Necrosis Factor-Alpha Inhibitors
7.4.4. Immunostimulants
7.4.5. GPCR Modulators
7.4.6. Others
7.5. Market Segmentation By Distribution Channel
7.5.1. Hospital Pharmacies
7.5.2. Retail Pharmacies
7.5.3. Online Pharmacies
8. Oral Biologics And Biosimilars Market, Supply Chain Analysis
8.1. Raw Material Suppliers
8.2. Contract Research Organization (CRO)
8.3. Oral Biologics And Biosimilars Manufacturers
8.3.1. Drug Discovery
8.3.2. Preclinical And Clinical Trials
8.3.3. Patents Upon Discovery And Approval
8.3.4. Drug Manufacturing
8.4. Contract Manufacturing Organization (CMO)
8.5. Wholesalers/Distributors
8.6. Retailers (Pharmacies) And Hospitals
8.7. End-Users
9. Oral Biologics & Biosimilars Market Product Analysis – Product Examples
10. Oral Biologics & Biosimilars Market, Product Pipeline Analysis
11. Oral Biologics and Biosimilars Market Customer Information
11.1. Knowledge Of Biosimilars And Its Difference From Generic Drugs
11.2. Patients’ Perspectives Concerning Biosimilars
11.3. Policies Implemented For Pricing Biosimilar Medicines In Different Countries
11.4. Patients Ready For Cost-saving Biosimilars
11.5. Physicians’ Knowledge And Attitudes Towards Biosimilars In Russia
11.6. Oral Version Of Biologics Could Improve Patient Medication Adherence
11.7. Canadian Physicians Are Familiar With Biosimilars But Lack Understanding
12. Oral Biologics & Biosimilars Market Trends And Strategies
12.1. Revised FDA Regulations To Facilitate Biologics Drug Development
12.2. Higher Profit Margins For Biologics
12.3. Shift From Small Molecules to Biologics
12.4. Microneedle Pills
12.5. New Insulin Biosimilars
12.6. Robust Research & Development
12.7. Large Number Of Strategic Partnerships
12.8. Extensive Use In Treatment Of Cancer, Diabetes And Other Autoimmune Diseases
12.9. Increase In Comfort & Compliance By Patients
13. Impact Of Covid-19 On Oral Biologics And Biosimilars Market R&D Funding
14. Global Oral Biologics & Biosimilars Comparative Analysis Of Overall Biologics & Oral Biologics
15. Global Oral Biologics & Biosimilars Rise & Evolution
15.1. Rise/Evolution Of Oral Biologics And Biosimilars
15.2. 2006-2015
15.3. 2017- Present Day
16. Oral Biologics & Biosimilars Companies’ Investment In Research And Development
16.1. Catalent Invested $214 Million To Improve Biologics And Oral Delivery Capabilities
16.2. TrueNorth Invested INR 536 Crore In Biocon Biologics
16.3. Fujifilm To Invest $928 Million To Expand Its Danish Biologics Production Facility
17. Major Oral Biologics & Biosimilars Developments By Disease
17.1. Diabetes
17.2. Cancer
17.3. Arthritis
17.4. Gastro Intestinal Disorders
17.5. Allergic Reactions
18. Global Oral Biologics & Biosimilars Market Size And Growth
18.1. Market Size
18.2. Historic Market Growth, 2015 – 2019, Value ($ Million)
18.2.1. Drivers Of The Market 2015 – 2019
18.2.2. Restraints On The Market 2015-19
18.3. Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
18.3.1. Drivers Of The Market 2019 – 2023
18.3.2. Restraints Of The Market 2019-2023
19. Global Oral Biologics & Biosimilars Market Segmentation
19.1. Global Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
19.1.1. Infectious Diseases
19.1.2. Diabetes
19.1.3. Other Autoimmune Diseases
19.1.4. Others
19.1.5. Cancer
19.1.6. Arthritis & Chron's Disease
19.2. Global Oral Biologics & Biosimilars Market, Segmentation By Molecule Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
19.2.1. Vaccines
19.2.2. Proteins & Peptides
19.2.3. Others
19.2.4. mAbs
19.3. Global Oral Biologics & Biosimilars Market, Segmentation By Therapeutic Mechanism Type, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
19.3.1. Immunostimulants
19.3.2. Others (Interferons, Opioid receptors, Calcitonin receptor etc)
19.3.3. GPCR (Insulin, Growth Hormone, Parathyroid Hormone)
19.3.4. TNF-Alpha
19.3.5. Lymphocyte Modulators
19.3.6. Interleukin Inhibitors
19.4. Global Oral Biologics & Biosimilars Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
19.4.1. Hospital Pharmacies
19.4.2. Retail Pharmacies
19.4.3. Online Pharmacies
20. Oral Biologics & Biosimilars Market, Regional And Country Analysis
20.1. Global Oral Biologics & Biosimilars Market, By Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
20.2. Global Oral Biologics & Biosimilars Market, By Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21. Asia-Pacific Oral Biologics & Biosimilars Market
21.1. Asia-Pacific Oral Biologics & Biosimilars Market Overview
21.1.1. Region Information
21.1.2. Market Information
21.1.3. Background Information
21.1.4. Government Initiatives
21.1.5. Regulations
21.1.6. Regulatory Bodies
21.1.7. Major Associations
21.1.8. Taxes Levied
21.1.9. Corporate Tax Structure
21.1.10. Investments
21.1.11. Major Companies
21.2. Asia-Pacific Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.3. Asia-Pacific Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.4. Asia-Pacific Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.5. Asia-Pacific Oral Biologics & Biosimilars Market: Country Analysis
21.6. China Oral Biologics & Biosimilars Market
21.7. China Oral Biologics & Biosimilars Market Overview
21.7.1. Country Information
21.7.2. Market Information
21.7.3. Background Information
21.7.4. Government Initiatives
21.7.5. Regulations
21.7.6. Regulatory Bodies
21.7.7. Major Associations
21.7.8. Taxes Levied
21.7.9. Corporate Tax Structure
21.7.10. Investments
21.7.11. Major Companies
21.8. China Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.9. China Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.10. China Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.11. India Oral Biologics & Biosimilars Market
21.12. India Oral Biologics & Biosimilars Market Overview
21.12.1. Country Information
21.12.2. Market Information
21.12.3. Background Information
21.12.4. Government Initiatives
21.12.5. Regulations
21.12.6. Regulatory Bodies
21.12.7. Major Associations
21.12.8. Taxes Levied
21.12.9. Corporate Tax Structure
21.12.10. Investments
21.12.11. Major Companies
21.13. India Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.14. India Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.15. India Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.16. Japan Oral Biologics & Biosimilars Market
21.17. Japan Oral Biologics & Biosimilars Market Overview
21.17.1. Country Information
21.17.2. Market Information
21.17.3. Background Information
21.17.4. Government Initiatives
21.17.5. Regulations
21.17.6. Regulatory Bodies
21.17.7. Major Associations
21.17.8. Taxes Levied
21.17.9. Corporate Tax Structure
21.17.10. Investments
21.17.11. Major Companies
21.18. Japan Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.19. Japan Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.20. Japan Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.21. Australia Oral Biologics & Biosimilars Market
21.22. Australia Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.23. Australia Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.24. Australia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.25. Indonesia Oral Biologics & Biosimilars Market
21.26. Indonesia Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.27. Indonesia Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.28. Indonesia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
21.29. South Korea Oral Biologics & Biosimilars Market
21.30. South Korea Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
21.31. South Korea Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
21.32. South Korea Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
22. Western Europe Oral Biologics & Biosimilars Market
22.1. Western Europe Oral Biologics & Biosimilars Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. Background Information
22.1.4. Government Initiatives
22.1.5. Regulations
22.1.6. Regulatory Bodies
22.1.7. Major Associations
22.1.8. Taxes Levied
22.1.9. Corporate Tax Structure
22.1.10. Investments
22.1.11. Major Companies
22.2. Western Europe Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
22.3. Western Europe Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
22.4. Western Europe Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
22.5. Western Europe Oral Biologics & Biosimilars Market: Country Analysis
22.6. UK Oral Biologics & Biosimilars Market
22.7. UK Oral Biologics & Biosimilars Market Overview
22.7.1. Country Information
22.7.2. Market Information
22.7.3. Background Information
22.7.4. Government Initiatives
22.7.5. Regulations
22.7.6. Regulatory Bodies
22.7.7. Major Associations
22.7.8. Taxes Levied
22.7.9. Corporate Tax Structure
22.7.10. Investments
22.7.11. Major Companies
22.8. UK Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
22.9. UK Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
22.10. UK Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
22.11. Germany Oral Biologics & Biosimilars Market
22.12. Germany Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
22.13. Germany Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
22.14. Germany Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
22.15. France Oral Biologics & Biosimilars Market
22.16. France Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
22.17. France Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
22.18. France Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
23. Eastern Europe Oral Biologics & Biosimilars Market
23.1. Eastern Europe Oral Biologics & Biosimilars Market Overview
23.1.1. Region Information
23.1.2. Market Information
23.1.3. Background Information
23.1.4. Government Initiatives
23.1.5. Regulations
23.1.6. Regulatory Bodies
23.1.7. Major Associations
23.1.8. Investments
23.1.9. Taxes Levied
23.1.10. Corporate Tax Structure
23.1.11. Major Companies
23.2. Eastern Europe Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
23.3. Eastern Europe Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
23.4. Eastern Europe Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
23.5. Eastern Europe Oral Biologics & Biosimilars Market: Country Analysis
23.6. Russia Oral Biologics & Biosimilars Market
23.7. Russia Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
23.8. Russia Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
23.9. Russia Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
24. North America Oral Biologics & Biosimilars Market
24.1. North America Oral Biologics & Biosimilars Market Overview
24.1.1. Region Information
24.1.2. Market Information
24.1.3. Background Information
24.1.4. Government Initiatives
24.1.5. Regulations
24.1.6. Regulatory Bodies
24.1.7. Major Associations
24.1.8. Taxes Levied
24.1.9. Corporate Tax Structure
24.1.10. Investments
24.1.11. Major Companies
24.2. North America Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
24.3. North America Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
24.4. North America Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
24.5. North America Oral Biologics & Biosimilars Market: Country Analysis
24.6. USA Oral Biologics & Biosimilars Market
24.7. USA Oral Biologics & Biosimilars Market Overview
24.7.1. Country Information
24.7.2. Market Information
24.7.3. Background Information
24.7.4. Government Initiatives
24.7.5. Regulations
24.7.6. Regulatory Bodies
24.7.7. Major Associations
24.7.8. Tax Levied
24.7.9. Corporate Tax Structure
24.7.10. Investments
24.7.11. Major Companies
24.8. USA Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
24.9. USA Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
24.10. USA Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
25. South America Oral Biologics & Biosimilars Market
25.1. South America Oral Biologics & Biosimilars Market Overview
25.1.1. Region Information
25.1.2. Market Information
25.1.3. Background Information
25.1.4. Government Initiatives
25.1.5. Regulations
25.1.6. Regulatory Bodies
25.1.7. Major Associations
25.1.8. Taxes Levied
25.1.9. Corporate Tax Structure
25.1.10. Investments
25.1.11. Major Companies
25.2. South America Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
25.3. South America Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
25.4. South America Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
25.5. South America Oral Biologics & Biosimilars Market: Country Analysis
25.6. Brazil Oral Biologics & Biosimilars Market
25.7. Brazil Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
25.8. Brazil Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
25.9. Brazil Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
26. Middle East Oral Biologics & Biosimilars Market
26.1. Middle East Oral Biologics & Biosimilars Market Overview
26.1.1. Region Information
26.1.2. Market Information
26.1.3. Background Information
26.1.4. Government Initiatives
26.1.5. Regulations
26.1.6. Regulatory Bodies
26.1.7. Major Associations
26.1.8. Taxes Levied
26.1.9. Corporate Tax Structure
26.1.10. Investments
26.1.11. Major Companies
26.2. Middle East Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
26.3. Middle East Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
26.4. Middle East Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
27. Africa Oral Biologics & Biosimilars Market
27.1. Africa Oral Biologics & Biosimilars Market Overview
27.1.1. Region Information
27.1.2. Market Information
27.1.3. Background Information
27.1.4. Regulations
27.1.5. Regulatory Bodies
27.1.6. Major Associations
27.1.7. Taxes Levied
27.1.8. Corporate Tax Structure
27.1.9. Investments
27.1.10. Major Companies
27.2. Africa Oral Biologics & Biosimilars Market, Historic Market Growth, 2015 – 2019, Value ($ Million)
27.3. Africa Oral Biologics & Biosimilars Market, Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
27.4. Africa Oral Biologics & Biosimilars Market, Segmentation By Disease, Historic And Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
28. Global Oral Biologics & Biosimilars Market Competitive Landscape
28.1. Company Profiles
28.2. Merck & Co.
28.2.1. Company Overview
28.2.2. Products And Services
28.2.3. Business Strategy
28.2.4. Financial Overview
28.3. GlaxoSmithKline
28.3.1. Company Overview
28.3.2. Products And Services
28.3.3. Financial Overview
28.4. Novo Nordisk
28.4.1. Company Overview
28.4.2. Products And Services
28.4.3. Business Strategy
28.4.4. Financial Overview
28.5. ALK-Abello A/S
28.5.1. Company Overview
28.5.2. Products And Services
28.5.3. Business Strategy
28.5.4. Financial Overview
28.6. Aimmune Therapeutics, Inc.
28.6.1. Company Overview
28.6.2. Products And Services
28.6.3. Business Strategy
28.6.4. Financial Overview
29. Key Mergers And Acquisitions In The Oral Biologics & Biosimilars Market
29.1. Abbvie Acquired Allergan
29.2. Takeda Pharmaceutical Company Acquired PvP Biologics, Inc.
29.3. True North Acquired Stake In Biocon Biologics
29.4. Catalent, Inc. Acquired Bristol Myers Squibb’s Oral Dose Manufacturing Facility
29.5. Amgen Acquired Psoriasis Drug Otezla From Celgene
29.6. Amgen’s Acquisition Of Otezla From Celgene
29.7. Bristol Myers Acquired Celgene
29.8. Biocon Acquires Pfizer's R&D Facility To Boost Biosimilars Development
29.9. Biocon Biologics Acquired R&D Facility From Pfizer Healthcare India
29.10. AstraZeneca Strikes Stock Deal With Daiichi Sankyo
29.11. Takeda Pharmaceutical Company Acquires Shire
29.12. Kashiv Pharma Acquired Adello Biologics
29.13. Stada Acquired Majority Stake In Bioceuticals
29.14. Catalent, Inc. Acquired Cook Pharmica LLC
30. Oral Biologics & Biosimilars Market Opportunities And Strategies
30.1. Global Oral Biologics & Biosimilars Market In 2023 – Countries Offering Most New Opportunities
30.2. Global Oral Biologics & Biosimilars Market In 2023 – Segments Offering Most New Opportunities
30.3. Global Oral Biologics & Biosimilars Market In 2023 – Growth Strategies
30.3.1. Market Trend Based Strategies
30.3.2. Competitor Strategies
31. Oral Biologics & Biosimilars Market, Conclusions And Recommendations
31.1. Conclusions
31.1.1. Product
31.1.2. Place
31.1.3. Price
31.1.4. Promotion
32. Appendix
32.1. Market Data Sources
32.2. Research Methodology
32.3. Currencies
32.4. Research Inquiries
32.5. The Business Research Company
32.6. Copyright and Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook